The below set of news items is a repository of all our press releases, statements, blogs and other news in chronological order.
Demographic changes mean that Europe's population is growing increasingly older and in need of more and better care. Eye conditions like cataract are among the most frequently encountered by Europe's elders and healthcare stakeholders have realised that patients must have a choice in accessing the best available treatment options. A conference on 9 July in the European Parliament brought together doctors, Commission representatives and policymakers to raise awareness on the issue. Hosted by MEP Heinz K. Becker (EPP), the conferenced launched policy recommendations on Healthcare and Active Ageing: Patient Choice in Cataract Care and shed light on a growing consensus that patient awareness of and access to ground-breaking cataract treaments must be improved.
The US FDA's premarket authorisation system for regulating high-risk medical devices not only delays patients' access to potentially life-saving technologies but does not safeguard them against risky products any more than the EU's CE marking process.
Moreover, it has a detrimental impact on small companies with limited resources which could cause these companies to stop operating, to the detriment of the development of innovative technologies in the US.
Yesterday the Emilia Romagna region in Italy was struck by a powerful earthquake. From the latest information in the media we understand that 17 people lost their life, over 350 people were injured and more than 13,000 people rendered homeless. The images of the devastation that have been reported out of Italy are truly heart breaking. In this region also many member companies of Eucomed are located such as B. Braun, Fresenius and Sorin.